These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 17785202)

  • 1. FGFR3 activates RSK2 to mediate hematopoietic transformation through tyrosine phosphorylation of RSK2 and activation of the MEK/ERK pathway.
    Kang S; Dong S; Gu TL; Guo A; Cohen MS; Lonial S; Khoury HJ; Fabbro D; Gilliland DG; Bergsagel PL; Taunton J; Polakiewicz RD; Chen J
    Cancer Cell; 2007 Sep; 12(3):201-14. PubMed ID: 17785202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New insights into RSK activation and hematopoietic cancer.
    Cuadrado A; Nebreda AR
    Cancer Cell; 2007 Sep; 12(3):187-9. PubMed ID: 17785199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidermal growth factor stimulates RSK2 activation through activation of the MEK/ERK pathway and src-dependent tyrosine phosphorylation of RSK2 at Tyr-529.
    Kang S; Dong S; Guo A; Ruan H; Lonial S; Khoury HJ; Gu TL; Chen J
    J Biol Chem; 2008 Feb; 283(8):4652-7. PubMed ID: 18156174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibroblast growth factor receptor 3 associates with and tyrosine phosphorylates p90 RSK2, leading to RSK2 activation that mediates hematopoietic transformation.
    Kang S; Elf S; Dong S; Hitosugi T; Lythgoe K; Guo A; Ruan H; Lonial S; Khoury HJ; Williams IR; Lee BH; Roesel JL; Karsenty G; Hanauer A; Taunton J; Boggon TJ; Gu TL; Chen J
    Mol Cell Biol; 2009 Apr; 29(8):2105-17. PubMed ID: 19223461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phosphoserine-regulated docking site in the protein kinase RSK2 that recruits and activates PDK1.
    Frödin M; Jensen CJ; Merienne K; Gammeltoft S
    EMBO J; 2000 Jun; 19(12):2924-34. PubMed ID: 10856237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Y-box binding protein-1 serine 102 is a downstream target of p90 ribosomal S6 kinase in basal-like breast cancer cells.
    Stratford AL; Fry CJ; Desilets C; Davies AH; Cho YY; Li Y; Dong Z; Berquin IM; Roux PP; Dunn SE
    Breast Cancer Res; 2008; 10(6):R99. PubMed ID: 19036157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p90 ribosomal S6 kinase 2 is associated with and dephosphorylated by protein phosphatase 2Cdelta.
    Doehn U; Gammeltoft S; Shen SH; Jensen CJ
    Biochem J; 2004 Sep; 382(Pt 2):425-31. PubMed ID: 15206906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ERK MAP kinase is targeted to RSK2 by the phosphoprotein PEA-15.
    Vaidyanathan H; Opoku-Ansah J; Pastorino S; Renganathan H; Matter ML; Ramos JW
    Proc Natl Acad Sci U S A; 2007 Dec; 104(50):19837-42. PubMed ID: 18077417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitogen-activated protein kinase pathway-dependent tumor-specific survival signaling in melanoma cells through inactivation of the proapoptotic protein bad.
    Eisenmann KM; VanBrocklin MW; Staffend NA; Kitchen SM; Koo HM
    Cancer Res; 2003 Dec; 63(23):8330-7. PubMed ID: 14678993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contrasting roles of neuronal Msk1 and Rsk2 in Bad phosphorylation and feedback regulation of Erk signalling.
    Clark CJ; McDade DM; O'Shaughnessy CT; Morris BJ
    J Neurochem; 2007 Aug; 102(4):1024-34. PubMed ID: 17663748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ERK/ribosomal S6 kinase (RSK) signaling positively regulates death receptor 5 expression through co-activation of CHOP and Elk1.
    Oh YT; Liu X; Yue P; Kang S; Chen J; Taunton J; Khuri FR; Sun SY
    J Biol Chem; 2010 Dec; 285(53):41310-9. PubMed ID: 21044953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ribosomal S6 kinase 2 is a key regulator in tumor promoter induced cell transformation.
    Cho YY; Yao K; Kim HG; Kang BS; Zheng D; Bode AM; Dong Z
    Cancer Res; 2007 Sep; 67(17):8104-12. PubMed ID: 17804722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MEK1-RSK2 contributes to Hedgehog signaling by stabilizing GLI2 transcription factor and inhibiting ubiquitination.
    Liu Z; Li T; Reinhold MI; Naski MC
    Oncogene; 2014 Jan; 33(1):65-73. PubMed ID: 23208494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ribosomal protein S6 kinase (RSK)-2 as a central effector molecule in RON receptor tyrosine kinase mediated epithelial to mesenchymal transition induced by macrophage-stimulating protein.
    Ma Q; Guin S; Padhye SS; Zhou YQ; Zhang RW; Wang MH
    Mol Cancer; 2011 May; 10():66. PubMed ID: 21619683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eriodictyol inhibits RSK2-ATF1 signaling and suppresses EGF-induced neoplastic cell transformation.
    Liu K; Cho YY; Yao K; Nadas J; Kim DJ; Cho EJ; Lee MH; Pugliese A; Zhang J; Bode AM; Dong Z; Dong Z
    J Biol Chem; 2011 Jan; 286(3):2057-66. PubMed ID: 21098035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kaempferol targeting on the fibroblast growth factor receptor 3-ribosomal S6 kinase 2 signaling axis prevents the development of rheumatoid arthritis.
    Lee CJ; Moon SJ; Jeong JH; Lee S; Lee MH; Yoo SM; Lee HS; Kang HC; Lee JY; Lee WS; Lee HJ; Kim EK; Jhun JY; Cho ML; Min JK; Cho YY
    Cell Death Dis; 2018 Mar; 9(3):401. PubMed ID: 29540697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain-derived neurotrophic factor stimulates the transcriptional and neuroprotective activity of myocyte-enhancer factor 2C through an ERK1/2-RSK2 signaling cascade.
    Wang Y; Liu L; Xia Z
    J Neurochem; 2007 Aug; 102(3):957-66. PubMed ID: 17630987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ribosomal S6 kinase 2 interacts with and phosphorylates PDZ domain-containing proteins and regulates AMPA receptor transmission.
    Thomas GM; Rumbaugh GR; Harrar DB; Huganir RL
    Proc Natl Acad Sci U S A; 2005 Oct; 102(42):15006-11. PubMed ID: 16217014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of protein synthesis in cardiomyocytes by the hypertrophic agent phenylephrine requires the activation of ERK and involves phosphorylation of tuberous sclerosis complex 2 (TSC2).
    Rolfe M; McLeod LE; Pratt PF; Proud CG
    Biochem J; 2005 Jun; 388(Pt 3):973-84. PubMed ID: 15757502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RSK2 and its binding partners in cell proliferation, transformation and cancer development.
    Cho YY
    Arch Pharm Res; 2017 Mar; 40(3):291-303. PubMed ID: 28013489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.